1.
Charrois-Durand C, Saad F, Barkati M, Lattouf J-B, Perrotte P, Karakiewicz PI, et al. A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer. CUAJ [Internet]. 27 janv. 2022 [cité 2 oct. 2026];16(6):199-205. Disponible à: https://cuaj.ca/index.php/journal/article/view/7591